A protein may be the key to unlocking a regular, healthy circadian rhythm no matter where (or when) in the world you are.

A drug company that made a $34,000-a-vial medicing has agreed to pay $100 million to settle a lawsuit alleging preventing competition.

Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion.

Pharmac announced today it would start funding the breast cancer drug Perjeta, but 160 Kiwis who have already started treatment won't be eligible.

AFT Pharmaceuticals widened its first-half loss after ramping up R&D and launching over-the-counter products in Australia and Singapore.

Kiwi experts are on the front lines fighting the "antibiotic apocalypse".

A major medical marijuana trial is underway in New Zealand - testing the effects of a new cannabis gel on epilepsy patients.

As a nationwide opioid epidemic raged, DEA investigators went after companies distributing millions of highly addictive pills. Then, their cases ground to a halt.

Douglas Pharmaceuticals expects the US market to become its biggest, overtaking the EU in the near future.

Ebos Group plans to sell its 270-store Chemmart business to Terry White Group and taking a 50 per cent stake in the enlarged pharmacy chain.

Martin Shkreli pleaded not guilty to a conspiracy charge accusing him of using employees and consultants to conceal his control of Retrophin Inc. stock.

The Auckland-based drug developer posted a $8.9 million operating loss for the year to March 31.

He plays the blues and is credited with figuring out how drug companies can justify hiking prices charged to vulnerable patients.

The New Zealand branch of the pharmaceutical giant Pfizer sent tens of millions offshore while paying virtually no tax.

Trade Minister Todd McClay says he sees no reason why big pharmaceutical firms would stop supplying new medicines in New Zealand.

No argument against the proposed TPP packs more emotional punch than the claim that the deal would be bad for people's health.

The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill.

The botox boom is hitting China - where it's the young, not the old getting the jab.

Australia's federal government has introduced draft laws allowing the cultivation and supply of marijuana for medicinal or scientific purposes.

Martin Shkreli is being sued by an artist who says his work was used on the Wu-Tang Clan album Shkreli paid $2 million for.

'Pharma-bro' Martin Shkreli has started a Twitter feud with Wu-Tang Clan.

The former chief executive of Turing Pharmaceuticals cannot stay out of the spotlight.

KaloBios Pharmaceuticals Inc. has filed for bankruptcy after the arrest of former CEO Martin Shkreli knocked the biotechnology company's brief revival off course.

Martin Shkreli terminated from drug company after being arrested on fraud charges.

The world's 'most hated CEO' who hiked the price of an essential drug by 5,000 per cent has likened himself to Robin Hood, John D Rockefeller, and the robber barons.

A reviled US pharmaceutical boss who caused a storm in September by jacking up the price of a life-saving drug by 5000 per cent has been arrested on fraud charges.

In New Zealand we have a love/hate relationship with Pharmac, the agency that decides which drugs our Government will pay for.

Two petitions are circulating for the funding of the new immunotherapy drug against melanoma, Keytruda.

Kiwis are waiting for more than 35 cost-effective medicines recommended by a Pharmac advisory committee, a lobby group for the pharmaceutical industry says.

Pharmac is possibly the most publicly respected body in this country.